# Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702)

> **NCT01109004** · PHASE3 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 758 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Lenalidomide
- **DRUG:** lenalidomide, bortezomib and dexamethasone
- **DRUG:** Lenalidomide

## Key facts

- **NCT ID:** NCT01109004
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2017-01-15
- **Final completion:** 2018-03-03
- **Target enrollment:** 758 (ACTUAL)
- **Last updated:** 2021-12-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01109004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01109004, "Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01109004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*